Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 41: 173-176, 1995;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Malinow, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Malinow, M. R.

Clinical Chemistry, Vol 41, 173-176, Copyright © 1995 by American Association for Clinical Chemistry

Plasma homocyst(e)ine and arterial occlusive diseases: a mini-review

MR Malinow
Oregon Regional Primate Research Center, Beaverton 97006.

Homocysteine (HCY), which is derived from the intracellular metabolism of methionine, is exported into plasma, where it circulates mostly in oxidized forms (i.e., homocystine and cysteine-HCY disulfide) and mainly bound to proteins. Concentrations of total HCY, or homocyst(e)ine [H(e)], are increased in 15-40% of patients with coronary, cerebral, or peripheral arterial diseases. Such association of H(e) with arterial occlusive diseases has been documented in retrospective, cross-sectional, and prospective studies. Concentrations of H(e) are also increased in subjects having thickened carotid arteries, as determined by ultrasonography, and who are asymptomatic for atherosclerosis. Statistical analyses of data from several series of patients demonstrate that H(e) concentrations are associated with coronary artery disease, independently from most other risk factors for atherosclerosis. The increased concentrations of H(e) are readily corrected by folic acid, occasionally supplemented with pyridoxine, vitamin B12, choline, or betaine. Whether these supplements affect the evolution of atherosclerotic disease needs to be established by prospective, placebo-controlled clinical trials.


The following articles in journals at HighWire Press have cited this article:


Home page
FASEB J.Home page
J. Zhou, G. H. Werstuck, S. Lhotak, Y. Y. Shi, V. Tedesco, B. Trigatti, J. Dickhout, A. K. Majors, P. M. DiBello, D. W. Jacobsen, et al.
Hyperhomocysteinemia induced by methionine supplementation does not independently cause atherosclerosis in C57BL/6J mice
FASEB J, July 1, 2008; 22(7): 2569 - 2578.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
E.-C. Chan, P.-Y. Chang, T.-L. Wu, and J. T. Wu
Enzymatic Assay of Homocysteine on Microtiter Plates or a TECAN Analyzer Using Crude Lysate Containing Recombinant Methionine {gamma}-Lyase
Ann. Clin. Lab. Sci., April 1, 2005; 35(2): 155 - 160.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
L. J. Langman, J. G. Ray, J. Evrovski, E. Yeo, and D. E.C. Cole
Hyperhomocyst(e)inemia and the Increased Risk of Venous Thromboembolism: More Evidence From a Case-Control Study
Arch Intern Med, April 10, 2000; 160(7): 961 - 964.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
V. Schachinger, M. B. Britten, M. Elsner, D. H. Walter, I. Scharrer, and A. M. Zeiher
A Positive Family History of Premature Coronary Artery Disease Is Associated With Impaired Endothelium-Dependent Coronary Blood Flow Regulation
Circulation, October 5, 1999; 100(14): 1502 - 1508.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
I. Bova, J. Chapman, C. Sylantiev, A. D. Korczyn, and N. M. Bornstein
The A677V Methylenetetrahydrofolate Reductase Gene Polymorphism and Carotid Atherosclerosis
Stroke, October 1, 1999; 30(10): 2180 - 2182.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. Andersson, A. Lindgren, M. Arnadottir, H. Prytz, and B. Hultberg
Thiols as a Measure of Plasma Redox Status in Healthy Subjects and in Patients with Renal or Liver Failure
Clin. Chem., July 1, 1999; 45(7): 1084 - 1087.
[Full Text] [PDF]


Home page
NEJMHome page
R. Ross
Atherosclerosis -- An Inflammatory Disease
N. Engl. J. Med., January 14, 1999; 340(2): 115 - 126.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Chen and R. Banerjee
Purification of Soluble Cytochrome b5 as a Component of the Reductive Activation of Porcine Methionine Synthase
J. Biol. Chem., October 2, 1998; 273(40): 26248 - 26255.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Wang, M. Yoshizumi, K. Lai, J.-C. Tsai, M. A. Perrella, E. Haber, and M.-E. Lee
Inhibition of Growth and p21ras Methylation in Vascular Endothelial Cells by Homocysteine but Not Cysteine
J. Biol. Chem., October 3, 1997; 272(40): 25380 - 25385.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
C. Cobbaert, J. C. Arentsen, P. Mulder, N. Hoogerbrugge, and J. Lindemans
Significance of various parameters derived from biological variability of lipoprotein(a), homocysteine, cysteine, and total antioxidant status
Clin. Chem., October 1, 1997; 43(10): 1958 - 1964.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Gulati, Z. Chen, L. C. Brody, D. S. Rosenblatt, and R. Banerjee
Defects in Auxiliary Redox Proteins Lead to Functional Methionine Synthase Deficiency
J. Biol. Chem., August 1, 1997; 272(31): 19171 - 19175.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Association for Clinical Chemistry.